These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 37526946)

  • 1. Nanoparticles with transformable physicochemical properties for overcoming biological barriers.
    Lu Q; Yu H; Zhao T; Zhu G; Li X
    Nanoscale; 2023 Aug; 15(32):13202-13223. PubMed ID: 37526946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart transformable nanomedicines for cancer therapy.
    Wang Y; Li S; Wang X; Chen Q; He Z; Luo C; Sun J
    Biomaterials; 2021 Apr; 271():120737. PubMed ID: 33690103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformable nanodrugs for overcoming the biological barriers in the tumor environment during drug delivery.
    Li X; Huang Z; Liao Z; Liu A; Huo S
    Nanoscale; 2023 May; 15(19):8532-8547. PubMed ID: 37114478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
    Wang Y; Cai R; Chen C
    Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smart Nanosystems for Overcoming Multiple Biological Barriers in Cancer Nanomedicines Transport: Design Principles, Progress, and Challenges.
    Lin G; Zhou J; Cheng H; Liu G
    Small; 2023 Jul; 19(28):e2207973. PubMed ID: 36971279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy.
    Jin Z; Gao Q; Wu K; Ouyang J; Guo W; Liang XJ
    Adv Drug Deliv Rev; 2023 Nov; 202():115111. PubMed ID: 37820982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond.
    Iqbal J; Abbasi BA; Ahmad R; Mahmood T; Ali B; Khalil AT; Kanwal S; Shah SA; Alam MM; Badshah H; Munir A
    Appl Microbiol Biotechnol; 2018 Nov; 102(22):9449-9470. PubMed ID: 30219952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrier permeation and improved nanomedicine delivery in tumor microenvironments.
    Liu J; Zhang J; Gao Y; Jiang Y; Guan Z; Xie Y; Hu J; Chen J
    Cancer Lett; 2023 May; 562():216166. PubMed ID: 37028698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological determinants and plausible '6R' roadmap for clinical success of nanomedicines.
    Shahiwala A
    Nanomedicine (Lond); 2023 Aug; 18(18):1207-1222. PubMed ID: 37650539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures.
    Murugan K; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Int J Nanomedicine; 2015; 10():2191-206. PubMed ID: 25834433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.
    Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H
    Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration and translocation of functional inorganic nanomaterials into biological barriers.
    Cong Y; Baimanov D; Zhou Y; Chen C; Wang L
    Adv Drug Deliv Rev; 2022 Dec; 191():114615. PubMed ID: 36356929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of Smart Size-, Surface-, and Shape-Switching Nanoparticles to Improve Therapeutic Efficacy.
    Li X; Montague EC; Pollinzi A; Lofts A; Hoare T
    Small; 2022 Feb; 18(6):e2104632. PubMed ID: 34936204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Polymeric Nanomedicines for Oncology: Perspectives and Future Directions.
    Fletcher NL; Kempe K; Thurecht KJ
    Macromol Rapid Commun; 2020 Sep; 41(18):e2000319. PubMed ID: 32767396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
    Patel P; Shah J
    Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size-Transformable Nanostructures: From Design to Biomedical Applications.
    Zhang X; Chen X; Song J; Zhang J; Ren X; Zhao Y
    Adv Mater; 2020 Dec; 32(48):e2003752. PubMed ID: 33103829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of tumour penetration by nanomedicines through strategies based on transport processes and barriers.
    Yang H; Tong Z; Sun S; Mao Z
    J Control Release; 2020 Dec; 328():28-44. PubMed ID: 32858072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.